Medicinova (MNOV) Change in Receivables (2014 - 2021)

Medicinova (MNOV) posted quarterly Change in Receivables of $4.0 million for Q1 2021, up 166.57% quarter-over-quarter from -$6.0 million in Q1 2014.

Medicinova (MNOV) Change in Receivables (2014 - 2021) Analysis & Trends

Medicinova (MNOV) has reported Change in Receivables for 2 consecutive years, with $4.0 million the latest figure, recorded in Q1 2021.

In Q1 2021, Change in Receivables changed N/A year-over-year to $4.0 million; the TTM figure through Mar 2021 stood at $4.0 million (changed N/A YoY), while the FY2014 annual figure was -$6.0 million, down 200.0% from the prior year.
Change in Receivables improved to $4.0 million in Q1 2021 per MNOV's latest filing, from -$6.0 million in the prior quarter.
Across five years, Change in Receivables topped out at $4.0 million in Q1 2021 and bottomed at $4.0 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	140.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	838.50 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-53.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	117.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	31.60 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	94.29 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	37.16 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Medicinova	68.42 Mn	68.42 Mn	317,759.00	-

Download Data